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SelectNet Works for Malaria ControlIn just a couple days, Youyou Tu, William C. Campbell and
Satoshi Omura will meet His Majesty King Carl XVI Gustaf
of Sweden to receive the Nobel Prize in Physiology or Medi-
cine. Tu’s discovery of artemisinin, a potent anti-malarial. and
Campbell and Omura’s work on ivermectin, a broad-spec-
trum antiparasitic drug, has helped to mitigate the burden
of parasitic diseases, especially in the developing world.
Despite all effort and advances, stopping the spread of pre-
ventable parasitic diseases remains an unmet goal. Bhatt
et al. (Bhatt et al., 2015) now present the first data-driven
comprehensive picture of how specific interventions for ma-
laria control have impacted the spread of this disease in the
past 15 years.A demonstration of how to set up a mosquito bed net. Image cour-
tesy of Andre Roussel, USAID.In 1978, every 6 seconds one child would die from malaria.
Today, one child still dies from malaria every minute. Malaria
is a burden of approximately 600,000 deaths every year,
concentrated largely in sub-Saharan Africa (Hemingway,
2015). First line treatment with the drug chloroquine and con-
trol of the exposure to the insect that transmits the disease
with indoor spraying of the insecticide DDT failed, mostly
due to acquisition of resistance by the Plasmodium—thema-
laria parasite, and the anopheline mosquitoes, the malaria
vector.
The critical turning point in the combat against the disease
was the launch of the Roll Back Malaria Initiative and the
wider development agenda around the United Nations Mil-
lennium Development Goals, kicked off in the year 2000.
The ambitious agenda: begin to reverse malaria incidence
and to halt malaria spread by 2015. Since then, funding for
malaria control has increased 20, split between access to
insecticide-treated bed nets, indoor residual spraying—ac-
tions to reduce exposure to the mosquitoes—prompt treat-
ment of clinical malaria cases, and substitution of old drugs
for highly efficacious artemisinin-based combination
therapy.Now that the benchmark year of 2015 has been reached,
Bhatt et al. attempt to quantify the prevalence of Plasmodium
falciparum infection and disease incidence across sub-Sa-
haran Africa from 2000 to 2015, as well as to define the role
major interventions have had in causing changes in malaria
endemicity. By modeling disease transmission, the authors
were able to generate counterfactual geospatial maps that
provide estimation of what malaria parasite prevalence rates
would look like today without each intervention. In total, they
estimate that 663 million clinical cases of malaria were
averted between 2000 and 2015. The distribution of bed
nets alone was responsible for 68% percent of this improve-
ment, followed by 22% resulting from artemisinin-based
combination therapy, and 10% from indoor residual spray-
ing. There are caveats to these numbers. For instance, they
vary to some extent within different territories, and they are
affected by how early and the scale that each intervention
was deployed. Nonetheless, it may come as a surprise that
such large fraction of the improvement can be attributed to
interventions focused on mosquito-control.
Although the incidence of malaria has decreased to half of
what it used to be 15 years ago, the new data suggest
caution. Millions of people are still at risk of malaria disease
and death in Africa, and rates of improvement slowed
down about 5% per year in 2013. Continued distribution of
bed nets, replacement of the old ones, surveillance for
arousal of parasite and mosquito resistance—already docu-
mented in other areas in the world—will be essential steps to
reduce the number of disease cases.
The World Health Organization and the Roll Back Malaria
Partnership now have moved onto defining goals and priority
actions for malaria control in the next 15 years period.
Beyond providing an accurate picture of the effectiveness
of malaria interventions in the recent past, the new data will
be crucial to inform policy agencies with an optimal strategy
for the future.
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